Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.For licensed clinicians. Educational demonstration on synthetic data. Never enter real patient identifiers or protected health information: everything runs in your browser and nothing is sent or stored. Clinical decision support only; not FDA cleared; physician review is required.
CPE-010 · Context triggers
PC-12: Glycemic assessment
Glycemic assessment. Evaluates PCOS criteria met or probable.
Active rulePriority 4PCOS engine v1.0.0
Condition
- PCOS criteria met or probable
- no glycemic assessment in the last 12 months (or in the last 36 months at low risk)
What it reports
- The 2023 guideline recommends assessing glycemic status at diagnosis and every 1 to 3 years according to risk
Recommended next steps (for physician review)
- A 75-g OGTT is the preferred test; HbA1c or fasting glucose are acceptable when it is not feasible
Diagnostic boundary
- A prompt.
Evidence
- EV-PCOS-2023Teede HJ, Tay CT, Laven JJE, et al. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-2469.Supports: Adult diagnosis: irregular cycles plus hyperandrogenism once other causes are excluded; ultrasound or AMH when one is missing Adolescent criteria require both irregular cycles and hyperandrogenism Glycemic, cardiometabolic, sleep and mood assessment; endometrial risk in prolonged anovulation
Cases where this rule fires
Open a case to see this rule fire with real inputs, then change the values until it stops.
Try Biod in your practice
The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.